[Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer].
Kardiologisk-endokrinologisk Afdeling H, Hillerød Hospital, Dyrehavevej 29, 3400 Hillerød, Denmark.Ugeskrift for laeger 11/2011; 173(48):3093-6.
The prevention of cancer treatment-induced bone loss in patients with prostate cancer due to gonadotropin-releasing hormone (GnRH)-agonist, GnRH-antagonist and orchidectomi therapy has a high priority. We present an algorithm for the prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.